Amplification of MYCN in neuroblastoma tumors correlates with high VRK1 gene expression and aggressiveness, although the levels of VRK1 do not correlate with the levels of MYCN expression in nonamplified tumors (Figure 5c). This evidence concerns the gene VRK1 and neuroblastoma.